Русский
Analysis of factors influencing the readiness for coronavirus vaccination: results of a survey of HIV-infected patients
DOI: https://dx.doi.org/10.18565/epidem.2021.11.3.28-33
Kuimova U.A., Belyaeva V.V., Kozyrina N.V., Kulabukhova E.I., Goliusova M.D., Narkevich A.N.
1) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; 2) Peoples’ Friendship University of Russia, Moscow, Russia; 3) Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia, Krasnoyarsk, Russia
Subjects and methods. The investigation conducted in the period February 9 to March 26, 2021, which involved 113 HIV-infected patients registered in the Specialized Research Department of AIDS Epidemiology and Prevention, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. The questionnaire method was used.
Results. 32.7% of the respondents expressed more likely a positive attitude to vaccination. A total of 23.9% of the respondents rated their coronavirus vaccination awareness as high as possible. Their readiness for vaccination was higher than that in respondents with low awareness (40.7 and 12.5%, respectively; p = 0.017). The information obtained from the attending physician (63.7%) was the most trusted when making a decision on vaccination in the surveyed group. 24.3% of the survey participants showed the maximum interest in obtaining information. 47.1% of them displayed their readiness for vaccination; 23.5% were unready for the latter.
Conclusion. The results of the study could identify the factors influencing the patient’s decision to be vaccinated against COVID-19, which should be taken into account when advising on vaccination issues.
Literature
1. Актуальная эпидемическая ситуация в России и мире 2021 год. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/epid.php [The current epidemic situation in Russia and the world in 2021]. Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. (In Russ.). https://www.rospotrebnadzor.ru/region/korono_virus/ epid.php 2. Ладная Н.Н., Козырина Н.В., Бабихина К.А., Михайлов А.В., Годлевская М.В., Егорова Н.В. и др. Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов в России и влияния эпидемии коронавирусной инфекции COVID-19 на оказание медицинской помощи при ВИЧ-инфекции». dannye-issledovaniya-vich-i-sovid-19.pdf Ladnaya N.N., Kozyrina N.V., Babikhina K.A., Mikhailov A.V., Godlevskaya M.V., Egorova N.V. et al. [Results of the study «Studying the prevalence of COVID- 19 coronavirus infection among HIV-infected patients in Russia and the impact of the COVID-19 coronavirus infection epidemic on the provision of medical care for HIV infection»]. (In Russ.). dannye-issledovaniya-vich-i-sovid-19.pdf 3. Кравченко А.В., Куимова У.А., Голиусова М.Д., Козырина Н.В., Кулабухова Е.И. Особенности течения коронавирусной инфекции у больных ВИЧ-инфекцией. Материалы Российской научно-практической конференции «Управляемые и другие социально-значимые инфекции: диагностика, лечение и профилактика». Спб., 3–4 февраля 2021 г. Журнал Инфектологии 2021; 13(1, приложение 1): 70–71. Kravchenko A.V., Kuimova U.A., Goliusova M.D., Kozyrina N.V., Kulabukhova E.I. [Features of the course of coronavirus infection in patients with HIV infection. Materials of the Russian scientific and practical conference «Controlled and other socially significant infections: diagnosis, treatment and prevention»]. St. Petersburg, February 3–4, 2021. Journal Infectology 2021; 13(1, Suppl. 1): 70–71. (In Russ.). 4. Hoffmann C., Casado J.L., Härter G., Vizcarra P., Moreno A., Cattaneo D. et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021; 22(5): 372–78. doi: 10.1111/hiv.13037. 5. Del Amo J., Polo R., Moreno S., Díaz A., Martínez E., Arribas J.R. et al.; The Spanish HIV/COVID-19 Collaboration. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann. Intern. Med. 2020; 173: 536–41. 6. Правила профилактики новой коронавирусной инфекции. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/about/info/news_time/news_details.php [Rules for the prevention of a new coronavirus infection]. Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. (In Russ.). https://www.rospotrebnadzor.ru/about/info/news_time/news_details. php 7. Вакцина для профилактики COVID-19. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/versuscovid.php [Vaccine for the prevention of COVID-1]. Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. (In Russ.). https:// www.rospotrebnadzor.ru/region/korono_virus/versuscovid.php 8. People with Certain Medical Conditions. Centers for desease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html 9. Guidance for COVID-19 and People with HIV. https://clinicalinfo.hiv.gov/en/guidelines/covid-19-and-persons-hiv-interim-guidance/interim-guidance-covid-19-and-persons-hiv 10. Вакцины от COVID-19 при ВИЧ. https://www.unaids.org/ru/resources/ documents/2021/covid19-vaccines-and-hiv [COVID-19 vaccines for HIV]. https://www.unaids.org/ru/resources/ documents/2021/covid19-vaccines-and-hiv 11 Вакцинация: ключ на старт! Аналитический обзор. M.: ВЦИОМ, 2020. https://wciom.ru/analytical-reviews/analiticheskii-obzor/vakcinacija-kljuch-na-start [Vaccination: the key to start! Analytical review]. Moscow, 2020. https://wciom.ru/analytical-reviews/analiticheskii-obzor/ vakcinacija-kljuch-na-start
About the Autors
Ulyana A. Kuimova, Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; ulyanakuimova@gmail.com; https:// orcid.org/0000-0002-1101-151X
Valentina V. Belyaeva, МD, Leading Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; labora-et-ora@yandex.ru; http://orcid.org/ 0000-0002-4621-7892
Nadezhda V. Kozyrina, Cand. Med. Sci., Researcher, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; nad-kozyrina@yandex.ru; http://orcid.org/0000-0001 -5134-0054
Ekaterina I. Kulabuhova, Infectiologist, Central Research Institute of Epidemiology, Russian Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being; Head, Laboratory of the Department of Infectious Diseases with Courses of Epidemiology and Phthisiology, Peoples’ Friendship University; ekulabukhova@mail.ru; http://orcid.org/0000-0003-3645-7275
Marina D. Goliusova, Infectiologist, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; mad2501@yandex.ru; https://orcid.org/ 0000-0002-5325-6857
Artem N. Narkevich, МD, Associate Professor, Head, Department of Medical Cybernetics and Informatics; Head, Laboratory of Medical Cybernetics and Management in Healthcare, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; narkevichart@gmail.com; http://orcid.org/0000-0002-1489-5058
Similar Articles
